/PRNewswire/ Caliway Biopharmaceuticals (Caliway) announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for the.
Dhruva explains how physicians reported a lack of understanding when it comes to the FDA approval process, especially regarding expedited approval pathways.
"Theradaptive gains FDA approval for Oasis spine fusion study, offering safer and more effective options for spinal fusions. 80 patients to test OsteoAdapt SP s
/PRNewswire/ NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today.